|
Name |
(r)-4,6,8-Trihydroxy-3,4-dihydro-1(2h)-naphthalenone
|
Molecular Formula | C10H10O4 | |
IUPAC Name* |
(4R)-4,6,8-trihydroxy-3,4-dihydro-2H-naphthalen-1-one
|
|
SMILES |
C1CC(=O)C2=C([C@@H]1O)C=C(C=C2O)O
|
|
InChI |
InChI=1S/C10H10O4/c11-5-3-6-7(12)1-2-8(13)10(6)9(14)4-5/h3-4,7,11-12,14H,1-2H2/t7-/m1/s1
|
|
InChIKey |
YIIXGDYMMKWBPB-SSDOTTSWSA-N
|
|
Synonyms |
(r)-4,6,8-trihydroxy-3,4-dihydro-1(2h)-naphthalenone
|
|
CAS | NA | |
PubChem CID | 129834663 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 194.18 | ALogp: | 0.8 |
HBD: | 3 | HBA: | 4 |
Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 77.8 | Aromatic Rings: | 2 |
Heavy Atoms: | 14 | QED Weighted: | 0.585 |
Caco-2 Permeability: | -5.016 | MDCK Permeability: | 0.00000631 |
Pgp-inhibitor: | 0.003 | Pgp-substrate: | 0.053 |
Human Intestinal Absorption (HIA): | 0.507 | 20% Bioavailability (F20%): | 0.988 |
30% Bioavailability (F30%): | 0.997 |
Blood-Brain-Barrier Penetration (BBB): | 0.259 | Plasma Protein Binding (PPB): | 53.96% |
Volume Distribution (VD): | 0.828 | Fu: | 47.84% |
CYP1A2-inhibitor: | 0.477 | CYP1A2-substrate: | 0.32 |
CYP2C19-inhibitor: | 0.053 | CYP2C19-substrate: | 0.087 |
CYP2C9-inhibitor: | 0.062 | CYP2C9-substrate: | 0.687 |
CYP2D6-inhibitor: | 0.057 | CYP2D6-substrate: | 0.288 |
CYP3A4-inhibitor: | 0.065 | CYP3A4-substrate: | 0.166 |
Clearance (CL): | 16.456 | Half-life (T1/2): | 0.773 |
hERG Blockers: | 0.013 | Human Hepatotoxicity (H-HT): | 0.098 |
Drug-inuced Liver Injury (DILI): | 0.317 | AMES Toxicity: | 0.329 |
Rat Oral Acute Toxicity: | 0.585 | Maximum Recommended Daily Dose: | 0.244 |
Skin Sensitization: | 0.894 | Carcinogencity: | 0.426 |
Eye Corrosion: | 0.03 | Eye Irritation: | 0.948 |
Respiratory Toxicity: | 0.711 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003000 | 1.000 | D07MGA | 0.338 | ||||
ENC004397 | 0.652 | D07EXH | 0.292 | ||||
ENC003216 | 0.592 | D04AIT | 0.263 | ||||
ENC005853 | 0.592 | D0R6BI | 0.260 | ||||
ENC006107 | 0.592 | D0K8KX | 0.256 | ||||
ENC002936 | 0.592 | D00ZFP | 0.234 | ||||
ENC002027 | 0.574 | D0O1UZ | 0.232 | ||||
ENC005395 | 0.574 | D08QJS | 0.231 | ||||
ENC004791 | 0.574 | D0Z1FX | 0.228 | ||||
ENC002252 | 0.574 | D03DXN | 0.221 |